Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
6.61
+0.11 (1.69%)
At close: Mar 9, 2026, 4:00 PM EDT
6.52
-0.09 (-1.31%)
After-hours: Mar 9, 2026, 7:53 PM EDT

Ginkgo Bioworks Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2019
Market Capitalization
3854725213,3342,85612,355
Upgrade
Market Cap Growth
-36.59%-9.39%-84.36%16.75%-76.89%-
Upgrade
Enterprise Value
4024333512,6881,61810,698
Upgrade
Last Close Price
6.618.319.8267.6067.60332.40
Upgrade
PS Ratio
2.262.782.3013.265.9839.37
Upgrade
PB Ratio
0.760.930.733.041.657.88
Upgrade
P/TBV Ratio
0.851.050.813.451.838.45
Upgrade
EV/Sales Ratio
2.362.551.5410.693.3934.09
Upgrade
Debt / Equity Ratio
0.870.870.650.220.260.02
Upgrade
Net Debt / Equity Ratio
0.030.03-0.13-0.64-0.50-0.97
Upgrade
Net Debt / EBITDA Ratio
-0.06-0.060.221.040.410.85
Upgrade
Net Debt / FCF Ratio
-0.10-0.100.252.102.874.92
Upgrade
Asset Turnover
0.140.140.150.120.210.23
Upgrade
Inventory Turnover
----51.9020.30
Upgrade
Quick Ratio
4.664.665.455.878.0912.51
Upgrade
Current Ratio
4.924.925.626.118.3812.79
Upgrade
Return on Equity (ROE)
-51.08%-51.08%-60.34%-63.02%-127.52%-180.29%
Upgrade
Return on Assets (ROA)
-15.42%-15.42%-19.67%-21.82%-59.54%-83.23%
Upgrade
Return on Capital Employed (ROCE)
-30.10%-30.10%-37.70%-48.90%-92.80%-94.40%
Upgrade
Earnings Yield
-81.29%-66.22%-104.94%-26.78%-73.72%-14.81%
Upgrade
FCF Yield
-46.45%-37.84%-73.31%-10.09%-10.66%-2.51%
Upgrade
Buyback Yield / Dilution
-6.87%-6.87%-6.76%-15.75%-23.48%-6.71%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.